LUTHERVILLE, Md., July 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest results achieved by the real-time, stop-sale system in Kansas. Data released by the National Precursor Log Exchange (NPLEx) for the first six months of 2012 shows electronic technology in the Sunflower State blocked the sale of more than 9,000 boxes of medicine containing pseudoephedrine (PSE) preventing more than 23,000 grams from potentially being diverted by meth criminals.
"In the very short time since Kansas' real-time, stop-sale technology became fully operational, the system has already proven to be an undeniable success," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "The technology allows retailers to block unlawful attempted purchases right at the sales counter and provides law enforcement with valuable data instantaneously. The success of NPLEx means that law-abiding consumers will continue to have access to the cold and allergy medicines they depend on for relief."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
|SOURCE National Association of Drug Diversion Investigators|
Copyright©2012 PR Newswire.
All rights reserved